CORONARYMinimize

Baroque Medical is the partner of choice and distributor for Abbott Vascular in Southern Africa. Abbott Vascular, a division of Abbott, is one of the world’s leading vascular care businesses. A global leader in the interventional cardiology medical device industry, Abbott Vascular, through the offices of Baroque Medical,  provides innovative, minimally invasive and cost-effective products for the treatment of cardiovascular disease. Our extensive CARDIOLOGY portfolio includes:

Drug-eluting coronary stents –    Everolimus Eluting stents ( Section 21) 
Cobalt chromium coronary stents –    Multilink Vision and Mini-Vision
Stainless steel coronary stents -     Multilink Ultra 
Guide wires -     Workhorse Wires – Frontline – Stainless Steel
       : High Torque Floppy
-     Workhorse Wires – Frontline – Elastinite: Balanced
       Middle Weight (BMW), Universal
-     Tortuos Anatomy – Whisper range
-     Extra Support – Balanced Heavy Weight (BHW)
-     Chronic Occlusion – CROSS-IT range and PILOT range
Coronary dilatation catheters -     Voyager RX, Voyager Over The Wire (OTW), Powersail
       Non Compliant (NC)
Saphenous Vein Graphs (SVG) protection device-     Emboshield 
Bleedback control valve -     Co- Pilot 
Accessories: -     Hemostatic Valves  
-     Indeflators
-     Guide wire Accessories
-     Accessory Kits

       

-     Torque Devices      

Angioplasty or Percutaneous Transluminal Coronary Angioplasty (PTCA) is a technique used in the Catheterization Laboratory to widen the narrowing in an artery without surgery. The basic idea of angioplasty is to position a catheter with a small inflatable balloon on the end within the narrowed section of the artery. The balloon is then inflated, which pushes outward against the narrowing and surrounding wall of the artery. The inflated balloon opens the narrowed artery by splitting and compressing the plaque and slightly stretching the wall of the artery.

The implantation of stents has increased dramatically in recent years. They are used for treatment of new lesions or blockages and in areas where restenosis (plaque build-up after treatment) has occurred. Stents maybe implanted after the completion of angioplasty.

Abbott Vascular is uniquely focused on transforming the treatment of vascular disease and improving patient care by combining the latest medical device innovations with world-class pharmaceuticals, investing in research and development and advancing medicine through training and education.

Headquartered in Northern California, Abbott Vascular offers a comprehensive portfolio of coronary products, which are recognized internationally for their safety, effectiveness and ease of use in treating patients with vascular disease.

All these products are approved by EC and/or FDA

Baroque Medical is the partner of choice to Abbott Vascular and seeks to provide customers with clinically relevant, innovative and cost-effective products that improve the quality of life.

Baroque Medical is the partner of choice and distributor for Abbott Vascular in Southern Africa. Abbott Vascular, a division of Abbott, is one of the world’s leading vascular care businesses. A global leader in the interventional cardiology medical device industry, Abbott Vascular, through the offices of Baroque Medical,  provides innovative, minimally invasive and cost-effective products for the treatment of cardiovascular disease. Our extensive CARDIOLOGY portfolio includes:

Drug-eluting coronary stents –    Everolimus Eluting stents ( Section 21) 
Cobalt chromium coronary stents –    Multilink Vision and Mini-Vision
Stainless steel coronary stents -     Multilink Ultra 
Guide wires -     Workhorse Wires – Frontline – Stainless Steel
       : High Torque Floppy
-     Workhorse Wires – Frontline – Elastinite: Balanced
       Middle Weight (BMW), Universal
-     Tortuos Anatomy – Whisper range
-     Extra Support – Balanced Heavy Weight (BHW)
-     Chronic Occlusion – CROSS-IT range and PILOT range
Coronary dilatation catheters -     Voyager RX, Voyager Over The Wire (OTW), Powersail
       Non Compliant (NC)
Saphenous Vein Graphs (SVG) protection device-     Emboshield 
Bleedback control valve -     Co- Pilot 
Accessories: -     Hemostatic Valves  
-     Indeflators
-     Guide wire Accessories
-     Accessory Kits

       

-     Torque Devices      

Angioplasty or Percutaneous Transluminal Coronary Angioplasty (PTCA) is a technique used in the Catheterization Laboratory to widen the narrowing in an artery without surgery. The basic idea of angioplasty is to position a catheter with a small inflatable balloon on the end within the narrowed section of the artery. The balloon is then inflated, which pushes outward against the narrowing and surrounding wall of the artery. The inflated balloon opens the narrowed artery by splitting and compressing the plaque and slightly stretching the wall of the artery.

The implantation of stents has increased dramatically in recent years. They are used for treatment of new lesions or blockages and in areas where restenosis (plaque build-up after treatment) has occurred. Stents maybe implanted after the completion of angioplasty.

Abbott Vascular is uniquely focused on transforming the treatment of vascular disease and improving patient care by combining the latest medical device innovations with world-class pharmaceuticals, investing in research and development and advancing medicine through training and education.

Headquartered in Northern California, Abbott Vascular offers a comprehensive portfolio of coronary products, which are recognized internationally for their safety, effectiveness and ease of use in treating patients with vascular disease.

All these products are approved by EC and/or FDA

Baroque Medical is the partner of choice to Abbott Vascular and seeks to provide customers with clinically relevant, innovative and cost-effective products that improve the quality of life.


Print  
 POSSISMinimize

Baroque Medical is the partner of choice and distributor for Possis, pioneering the leading technology to quickly, safely and effectively remove intra-vascular blood clots (thrombus). The purpose of Possis devices is simple; save the lives and limbs of patients who suffer from these circulation-blocking clots.  Possis have proven core technologies, a strong pipeline of new products, cutting edge clinical science and a well-defined path for future growth.

Premiering in 1997, Possis' Angiojet® Rheolytic™ Thrombectomy System remains the medical world's leading mechanical Thrombectomy system. Over 300,000 patients worldwide have been treated with Angiojet therapy.

The Angiojet system comprises the following:

  • Control console
  • A family of catheters, each designed for optimal performance in different vascular territories.
  • Widely recognized by physicians as quick, safe and effective, the market-leading Angiojet technology is FDA cleared for use in:
    • Coronary arteries
    • Bypass grafts
    • Dialysis access grafts
    • Peripheral arteries
    • Peripheral veins

The goal moving forward is to expand the use of Angiojet Thrombectomy throughout the body - including new areas such as treating Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) and ischemic stroke.

Possis is looking beyond the current Thrombectomy market and is focusing on introducing new products that address unmet needs in the broader endovascular treatment market. The Fetch™ Aspiration Catheter is an example of our broader product focus.

With headquarters and manufacturing facilities in Minneapolis, Minnesota, the Company has a dedicated domestic sales force of over 80 people and is represented internationally by 15 distributors.

Baroque Medical is the partner of choice to Possis and seeks to provide customers with clinically relevant, innovative and cost-effective products that improve the quality of life.

 

 

 

 

Baroque Medical is the partner of choice and distributor for Possis, pioneering the leading technology to quickly, safely and effectively remove intra-vascular blood clots (thrombus). The purpose of Possis devices is simple; save the lives and limbs of patients who suffer from these circulation-blocking clots.  Possis have proven core technologies, a strong pipeline of new products, cutting edge clinical science and a well-defined path for future growth.

Premiering in 1997, Possis' Angiojet® Rheolytic™ Thrombectomy System remains the medical world's leading mechanical Thrombectomy system. Over 300,000 patients worldwide have been treated with Angiojet therapy.

The Angiojet system comprises the following:

  • Control console
  • A family of catheters, each designed for optimal performance in different vascular territories.
  • Widely recognized by physicians as quick, safe and effective, the market-leading Angiojet technology is FDA cleared for use in:
    • Coronary arteries
    • Bypass grafts
    • Dialysis access grafts
    • Peripheral arteries
    • Peripheral veins

The goal moving forward is to expand the use of Angiojet Thrombectomy throughout the body - including new areas such as treating Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) and ischemic stroke.

Possis is looking beyond the current Thrombectomy market and is focusing on introducing new products that address unmet needs in the broader endovascular treatment market. The Fetch™ Aspiration Catheter is an example of our broader product focus.

With headquarters and manufacturing facilities in Minneapolis, Minnesota, the Company has a dedicated domestic sales force of over 80 people and is represented internationally by 15 distributors.

Baroque Medical is the partner of choice to Possis and seeks to provide customers with clinically relevant, innovative and cost-effective products that improve the quality of life.

 

 

 

 


Print  
Home    About Us    Crossroads institute    Neuro     Endovascular    Coronary    Careers    Contact
Copyright 2007 by Win on the Web | Terms Of Use | Privacy Statement | WoW Interactive
Register
Login